Skip to content
★ Sign in to follow
SN

Spago nano medical AB Stock: price and insider trades · Sweden

ISIN SE0029278142SE·

No insider purchase over the last 90 days. The latest, by Mikael Lönn, was filed 18 Jun 2026.

Spago nano medical AB: what insiders have been doing

Spago nano medical AB is a listed company. Its insiders report their share dealings to Finansinspektionen. In the past year (31 October 2025 to 31 October 2026), 2 filings came from 1 insider.

No insider sold shares on the market over the period. Instead, the filings list 1 purchase totalling €136k, made by 1 insider. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Among those who bought: 1 board member. One trade stands out by size: a purchase of €136k from Mikael Lönn, disclosed on 18 June 2026.

The most recent open-market purchase was published on 18 June 2026, 143 days ago.

For context, the typical company on the same exchange (median of 1,031 companies) published 9 filings over the same period, against 2 filings here. Our records for Spago nano medical AB go back to 2016, with 8 purchases and no sales on the open market in total.

In the same market, recent insider purchases at Linc AB and Dynavox Group AB also feature in our signals. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.

Insider Decl.
14
Thresholds
n/a
Buy Volume
€755,822
8 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
Mikael Lönn1 buy

Financial data

· cache

Analyst consensus
·
Income statement
EBITDA-26.3M
Valuation
Beta1.30
Profitability & ownership
ROE-104.1%
ROA-54.4%
Last declaration on 18 June 2026
Declarations14 total
  • ●
    StyrelseledamotExecutives
    2M SEK0FI-SE
    15,833,331 shares@ SEK 0.1154.0% of flowBTA (betald tecknad aktie)ISIN SE0029278142FI:csv-421b4d2a2b342cdb07b5
  • ▲
    StyrelseledamotExecutives
    1M SEK0FI-SE
    13,504,500 shares@ SEK 0.1146.0% of flowBTA (betald tecknad aktie)ISIN SE0029278142FI:csv-7737c361cda888789d9b
    Canonical exit: 15 Sept 2026 (T+90)
  • ●
    Styrelseledamot/suppleantExecutives
    9,520 SEK0FI-SE
    4,000 shares@ SEK 2.38100.0% of flowTeckningsoptionISIN SE0013514031FI:csv-786b6c2b1ca4e1169332
  • ●
    ForskningschefExecutives
    80,002 SEK6FI-SE
    9,412 shares@ SEK 8.5042.2% of flowInlösenaktieISIN SE0010440842FI:csv-1358fe989628328ca9f0
  • ●
    VDExecutives
    49,861 SEK25FI-SE
    5,866 shares@ SEK 8.5026.0% of flowInterimsaktieISIN SE0012325249FI:csv-a8b1b17f8dc3a9890083
  • ●
    VDExecutives
    0FI-SE
    29,330 shares0OptionISIN SE0010440842FI:csv-da8ed9e2cfef48c74e28
  • ●
    Styrelseledamot/suppleantExecutives
    10M SEK15FI-SE
    797,220 shares@ SEK 12.85100.0% of flowAktieISIN SE0004899474FI:csv-1eaa4858dd1758e56d93
  • ▲
    Related company / holdingExecutives
    1M SEK30FI-SE
    165,843 shares@ SEK 8.50100.0% of flowISIN SE0010440834FI:csv-74655de5ee1051d1ed03
    Canonical exit: 4 Jan 2018 (T+90)
  • ▲
    Vice VD,ForskningschefExecutives
    100,003 SEK40FI-SE
    11,765 shares@ SEK 8.5057.8% of flowISIN SE0010440834FI:csv-dd8b31c1b6d43fad2d5b
    Canonical exit: 4 Jan 2018 (T+90)
  • ▲
    StyrelseordförandeExecutives
    2M SEK15FI-SE
    288,937 shares@ SEK 8.50100.0% of flowISIN SE0010440834FI:csv-efa29e8854da0136aeb9
    Canonical exit: 4 Jan 2018 (T+90)
  • ▲
    Board memberExecutives
    96,000 SEK27FI-SE
    8,000 shares@ SEK 12.00100.0% of flowISIN SE0004899474FI:csv-809c0df2e384dfac3e2f
    Canonical exit: 14 Mar 2017 (T+90)
  • ▲
    VDExecutives
    12,540 SEK35FI-SE
    1,000 shares@ SEK 12.546.9% of flowISIN SE0004899474FI:csv-ac9047cca49a41ed6805
    Canonical exit: 14 Feb 2017 (T+90)
  • ▲
    VDExecutives
    120,000 SEK29FI-SE
    10,000 shares@ SEK 12.0067.1% of flowISIN SE0004899474FI:csv-51aea7340573292ec450
    Canonical exit: 14 Mar 2017 (T+90)
  • ▲
    StyrelseordförandeExecutives
    2M SEK15FI-SE
    150,000 shares@ SEK 12.00100.0% of flowISIN SE0004899474FI:csv-a9eb47685862b350d6a4
    Canonical exit: 6 Feb 2017 (T+90)

14 of 14 declarations

About Spago nano medical AB

Spago nano medical AB is a company focused on developing targeted cancer treatments using nanomedicine technologies. It is listed on the Stockholm Stock Exchange (XSTO).

Recent ranked signals on the same market

Purchases our model currently ranks for the recommendations list.

All recommendations